Dr. Thomas A. McElhannon, MD

Dr. McElhannon practices at Piedmont Athens Primary Care in Watkinsville, Georgia.

Dr. McElhannon's NPI, 1407884893, was assigned on June 28, 2006. Dr. McElhannon graduated from Medical College of Georgia School of Medicine in 1996. Dr. McElhannon holds Georgia license 047618.

Dr. McElhannon's primary practice is Piedmont Athens Primary Care, at 1305 Jennings Mill Rd, Watkinsville, GA 30677 in Oconee County. The practice phone is (706) 369-5440.

Dr. McElhannon's primary practice is Piedmont Athens Primary Care in Watkinsville, Georgia. Dr. McElhannon is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is Piedmont QuickCare - Stockbridge, GA. Dmand AI also links Dr. McElhannon to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McElhannon practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. McElhannon's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. McElhannon is licensed in Georgia.

CMS data shows 2,764 Medicare services from Dr. McElhannon across 16 procedure codes in 2024, for 315 Medicare patients. Medicare paid $72,609 for them. Every service was in an office.

CMS counts 315 Medicare patients who saw Dr. McElhannon in 2024. The largest group is 65 to 74, with 144 patients. 73% of them have high blood pressure, and 62% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McElhannon's median patient age at 60, with 52% women.

In 2024, Dr. McElhannon wrote 11,775 Medicare Part D claims for 647 patients. 88% of them were for generic drugs. CMS names the drug for 10,979 of them, across 171 drugs with 11 or more claims each, at $950,897 in total drug cost. In 2023, CMS named 11,197 claims across 180 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. McElhannon for performance year 2024, reported through an alternative payment model (APM). Dr. McElhannon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 384 general payments to Dr. McElhannon from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Biohaven Pharmaceuticals, Inc. paid the most, $1,316.

Dr. McElhannon graduated from Medical College of Georgia School of Medicine in 1996.